Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

B Data demonstrate preclinical proof-of-concept for HWK-007, HWK-016 and HWK-206, underpinned by Whitehawk’s proprietary Carbon Bridge Cysteine Re-pairing platform Tumor regressions observed across various cancer…
posteditor
posteditor
Articles: 16137

Other News